300060110023

The barcode 300060110023 is associated with Vioxx, a medication produced by Merck Sharp & Dohme that contains rofecoxib at a dosage of 25 mg per tablet. Vioxx was primarily prescribed for the treatment of pain, inflammation, and stiffness associated with conditions like osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.

The 2-tablet pack labeled as a "Doctor Sample" indicates that it is typically provided by healthcare providers for patients to assess its effectiveness or suitability for their condition without the patient needing to purchase a full prescription initially.

Despite its therapeutic uses, it's crucial to note that Vioxx was withdrawn from the market in 2004 after studies indicated a significant increase in the risk of cardiovascular events, such as heart attacks and strokes, associated with its use over extended periods. This led to considerable scrutiny and concern within the medical community regarding the safety of COX-2 inhibitors, the class of drugs Vioxx belongs to.

As for the pricing, while it may have varied based on location and market conditions at the time of its availability, a 2022 estimation suggested that a 2-tablet package of Vioxx (25 mg) could cost between $60 to $80 USD. However, these figures may have changed, especially since the medication is no longer widely available due to its withdrawal.

In terms of health-related disclaimers, the FDA mandates that serious side effects must be highlighted for prescription medications, particularly those that carry boxed warnings. Given Vioxx's association with heightened cardiovascular risks, such information would be pertinent for patients. Thus, it is essential for individuals considering alternatives or past users of Vioxx to be aware of these risks and consult healthcare professionals for guidance.

For further details specific to the medication or updates on its status, individuals should consult a healthcare professional or refer to reliable medical resources.